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detection by non-professionals in family. The detection results can be uploaded to the data center through the mobile
terminal application (APP), and the report of intelligent
analysis can be obtained immediately. This technology presents high throughput, low cost, automation, and convenience. In response to severe epidemics, the government and
related departments can get the total number of infected
people and their geographical location in real time, and implement precise measures for the prevention and control on
this basis. Self-service diagnosis still has many technical
difficulties which need to be solved. The development of
self-service detection technology in family will tremendously
reduce the social cost for the prevention and control of major
infectious diseases. Biotechnology is now in an era of wide
cross, deep integration, and great breakthrough. Rapid diagnostic technology of infectious diseases has been integrating with information technology, nanotechnology, and
materials technology, facing the opportunity of achieving
significant breakthrough.

1 Developing self-service and rapid diagnostic
technology based on information technology

The development of automated rapid field pathogen detection technology from sample collection to result interpretation relies on the construction of the information-based
intelligent early warning system for infectious diseases. The
transmission of emerging infectious diseases usually follows
the rule of point–line–surface. Currently, infectious diseases
are mainly discovered in hospitals and reported to specialized
institutions such as the Center for Disease Control (CDC) to
make a judgment on the outbreak. However, at this time, the
outbreak is usually at the late stage of line transmission, or
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Infectious diseases have always been a major threat to the
survival of human beings, which has greatly influenced the
history of human civilization. The outbreak of COVID-19 in
early 2020 triggered a serious public health crisis in the globe
and made people to think deeply about the public health
emergency system.
Scientific and technological innovation is the key to the
prevention and control of emerging infectious diseases. Since
the beginning of the 21st century, biotechnology has developed rapidly and its integration with nanotechnology, information technology, precision electronics, and advanced
manufacturing has driven the industrial mode revolution and
the comprehensive upgrading of industrial technology. The
emergence of big data, cloud computing, and artificial intelligence provide new means for the prevention and control of
infectious diseases. At present, the development of these
technologies and the corresponding industries presents the
trend of automation, intelligentization, informatization, and
precision, which will alter the current passive response into a
timely, rapid, precise, and efficient active response to
emerging infectious diseases. Technological innovation
should be achieved through interdisciplinary efforts to establish a new paradigm for the prevention and control of
emerging infectious diseases.

The development of automated rapid field pathogen detection technology from sample collection to result interpretation makes it feasible to complete the self-service detection
in grass-roots medical institutions or even families. Originally, the detection can only be completed by professional
laboratories and relies on special conditions. The development and application of test strip can realize the rapid

2 Developing intelligent early warning system
for infectious diseases based on information
technology
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Developing broad-spectrum antiviral
specific drugs based on common mechanism
There are countless species and types of viruses. Besides,
viruses evolve because of gene mutations. Therefore, when
an epidemic occurs, it is difficult to develop specific drugs
from scratch in time. The research on the common mechanism of viral infection should be strengthened for the unveiling of broad-spectrum antiviral drugs based on common
mechanism. The expanding broad-spectrum antiviral drug
library can provide an effective means for us to deal with
emerging infectious diseases.
The development of broad-spectrum antiviral drugs can be
started from two aspects: the common mechanism of viral
infection and the innate immune mechanism against viral
infection.
(1) There are some common mechanisms of viral infection, which can be used as the breakthrough points in the
design of broad-spectrum antiviral drugs. ① Viral replication
requires viral polymerase to synthesize genetic material, and
the substrate recognition domain of viral polymerase is
highly conserved. ② Some key proteins of viruses have
conserved domains, such as hemagglutinin of influenza virus
and capsid protein of coronavirus, which can be used as targets for the design of broad-spectrum antiviral drugs. ③ The
new strategy to intervene in the unique mechanism of virus
frameshift translation should be developed to inhibit the
protein synthesis of virus.
(2) It is of great significance to strengthen the study on
human innate immunity against virus infection. It is the first
line of defense that the body has the ability of natural antiviral
immunity before producing specific immunity (neutralizing
antibody, etc.) after virus infection. The interferon production
induced by virus infection could be enhanced via glycosylation regulation, which would significantly promote the
elimination of virus from body. Strengthening such studies
would provide effective measures for the prevention and
control of emerging infectious diseases.
In conclusion, we should constantly strengthen the innovative layout and develop a new paradigm, so as to proactively construct an intelligent, efficient and characteristic
system for the prevention and control of emerging infectious
diseases, and build a strong shield for maintaining the national public health security and ensuring the health of the
people.
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even severer. The big data-based intelligent early warning
system involving cutting-edge biotechnology, information
technology, and artificial intelligence may discover emerging
infectious diseases at the first stage or even when the first
patient (point) appears, so as to realize real-time monitoring,
timely warning, early intervention, and thus the best prevention and control performance. For example, the intelligent
technology for the identification of pathogens (e.g., virus)
based on the big data of microbial genetic information can
realize the timely detection of the pathogens that may lead to
epidemics and thus the early warning. The development of
intelligent early warning system for emerging infectious
diseases is a complicated and systematic project, which requires the full cooperation of talents of multiple disciplines
such as big data, artificial intelligence, information technology, precision instrument, bioinformatics, microbiology,
epidemiology, and infectious diseases.
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3 Developing the big data-based intelligent
traceability system for infectious diseases
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Tracing of viruses and other pathogens is the key to block
the spread of infectious diseases. However, the experience of
dealing with epidemics in the past decades proves that it is
difficult to trace the pathogen accurately through traditional
methods. Generalized pathogen tracing involves genetic
evolution, host, and space and time. The coming era of big
data and the development of intelligent technology make it
possible to trace pathogen quickly and effectively. By tracing
the origin of viruses and other pathogens, we can reveal the
transmission of viruses among different individuals and different host species, as well as the evolution of them under the
selection pressure of different external environment and host
immune response. Moreover, the key molecular characteristics that determine their transmissibility, pathogenicity, and
drug resistance can be analyzed for the development of drugs
and vaccines and the formulation of intervention measures.
Therefore, it is of great importance to developing a big databased intelligent traceability system for infectious diseases to
realize the intelligent analysis of pathogen information
through big data mining technology, rapid and accurate
tracing of pathogen source, and effective prevention and
control of emerging infectious diseases.
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